@matthewherper Profile Page - Replyz

Skip past navigation
Skip to Sign in form
Skip to Join form

Try Mailstrom: the faster, smarter, free way to Inbox Zero.

@matthewherper New York

Forbes reporter covering science and medicine

48 Replies
15 Conversations
Twitter user

Conversations Started by matthewherper

See all 15 conversations

A patient saw the value of sharing her information with a company. Why isn't this a two-way street? #TEDMED

10:11AM Wed, April 17

I don't get it. What is the case for eLife versus PLOS? It sounds interesting, but not granular enough. #TEDMED

9:46AM Wed, April 17

Replies from matthewherper

See all 48 replies

@matthewherper New York

Plavix Shmavix. (Joking, but shouldn't that be priced in at this point?) It's not like they're $LLY or $AZN.

11:33AM Thu, June 23 2011

In reply to: " $BMY seems to be firing on all cylinders. So what are they doing wrong? What's the downside? " -Asked by @matthewherper

@matthewherper New York

Sorry, Patrick, there's always a bear argument. Maybe be happy that I can't figure it out just by looking? :)

11:50AM Thu, June 23 2011

In reply to: " Downside? What downside? RT @matthewherper $BMY seems to be firing on all cylinders. So what are they doing wrong? What's the downside? " -Asked by @mccannpj